Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2016 May 26;11(5):e0156386. doi: 10.1371/journal.pone.0156386

Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon

Vanderson Souza Sampaio 1,2,3, André Alexandre Gomes 1,2, Iran Mendonça Silva 1,2, Jacqueline Sachett 1,2, Luiz Carlos Lima Ferreira 1,2, Sâmella Oliveira 1,2, Meritxell Sabidò 1,4, Hipócrates Chalkidis 5, Maria Graças Vale Barbosa Guerra 1,2, Jorge Luis Salinas 6, Fan Hui Wen 7, Marcus Vinícius Guimarães Lacerda 1,8, Wuelton Marcelo Monteiro 1,2,*
Editor: José María Gutiérrez9
PMCID: PMC4881914  PMID: 27227455

Abstract

Background

A better knowledge of the burden and risk factors associated with severity due to spider bites would lead to improved management with a reduction of sequelae usually seen for this neglected health problem, and would ensure proper use of antivenoms in remote localities in the Brazilian Amazon. The aim of this study was to analyze the profile of spider bites reported in the state of Amazonas in the Western Brazilian Amazon, and to investigate potential risk factors associated with severity of envenomation.

Methodology/Principal Findings

We used a case-control study in order to identify factors associated with spider bite severity in the Western Brazilian Amazon from 2007 to 2014. Patients evolving to any severity criteria were considered cases and those with non-severe bites were included in the control group. All variables were retrieved from the official Brazilian reporting systems. Socioeconomical and environmental components were also included in a multivariable analysis in order to identify ecological determinants of incidence and severity. A total of 1,181 spider bites were recorded, resulting in an incidence of 4 cases per 100,000 person/year. Most of the spider bites occurred in males (65.8%). Bites mostly occurred in rural areas (59.5%). The most affected age group was between 16 and 45 years old (50.9%). A proportion of 39.7% of the bites were related to work activities. Antivenom was prescribed to 39% of the patients. Envenomings recorded from urban areas [Odds ratio (OR) = 0.40 (95%CI = 0.30–0.71; p<0.001)] and living in a municipality with a mean health system performance index (MHSPI >median [OR = 0.64 (95%CI = 0.39–0.75; p<0.001)] were independently associated with decreased risk of severity. Work related accidents [OR = 2.09 (95%CI = 1.49–2.94; p<0.001)], Indigenous status [OR = 2.15 (95%CI = 1.19–3.86; p = 0.011)] and living in a municipality located >300 km away from the state capital Manaus [OR = 1.90 (95%CI = 1.28–2.40; p<0.001)] were independently associated with a risk of severity. Living in a municipality located >300 km away from the state capital Manaus [OR = 1.53 (95%CI = 1.15–2.02; p = 0.003)] and living in a municipality with a MHSPI <median [OR = 1.91 (95%CI = 1.28–2.47; p = 0.002)] increased the odds of antivenom underdosage.

Conclusions

Spider bites is prevalent across the study region with a higher incidence in the rainy season in rural areas. Spider bites can be painful and lead to local manifestations but rarely result in life-threatening envenoming. Major local complications were dermonecrosis and secondary infection in cases diagnosed as Loxosceles bites. Based on the correlations shown here, envenomings occurring in remote rural areas, Indigenous status and living in a municipality located >300 km away from the state capital Manaus could be contributing factors to higher severity of spider envenomings in this area, as well as to antivenom underdosage.

Introduction

Spider bites are common in most parts of the world, but in general cause only minimal effects [1,2]. However, the epidemiology of this neglected condition differs throughout the world and its burden is often poorly estimated. There are few official surveillance systems for spider bites reporting annual or periodic epidemiological data on spider bites across the world. The American Association of Poison Control Centers [3], the Australian Poison Information Center [4] and the national surveillance system from the Brazilian Ministry of Health [5] provide data on spider bites at a national level by using different surveillance methods. In Brazil envenomations, among which is included spider bites, are notifiable injuries and that must be recorded in the Brazilian Notifiable Diseases Surveillance System [Sistema de Informação de Agravos de Notificação (SINAN)]. A total of 270,885 cases spider bites were recorded by the Brazilian surveillance system from 2000 to 2013, with a notable increasing trend in the period, from 3,257 cases in 2000 (1.9 cases/100,000 inhabitants) to 27,125 in 2013 (14.6 cases/100,000 inhabitants) [6]. The incidence is higher in Southern Brazil, with a rate of 60.5 cases/100,000 inhabitants in 2013. In the same year, there were 5.2 cases per 100,000 in the Brazilian Amazon [7]. The number of cases detected officially in the Amazon is probably much lower than the real number due to the difficulty for riverine and indigenous populations to reach health centers for treatment of venomous animal injuries. Indeed, an epidemiological survey carried out in the state of Acre, Western Brazilian Amazon, found that 7% of tappers and 11% of Amerindians were bitten by spiders at least once in their lifetime [8]. Moreover, the lethality rate from spider bites in the Amazon (0.2%) is almost seven times higher than in Southern country (0.03%) [9].

Spider bite envenoming is caused by the inoculation of spider toxins through the inoculum apparatus and may cause local and systemic changes. Latrodectism and loxoscelism are the most important clinical syndromes resulting from spider bites [10]. Latrodectism results from bites by widow spiders (Latrodectus spp) and causes local, regional, or generalized pain associated with non-specific symptoms and autonomic effects [1012]. Loxoscelism is caused by Loxosceles spp, and the cutaneous form manifests as pain and erythema that can develop into a necrotic ulcer. Systemic loxoscelism is characterised by intravascular haemolysis and renal failure [10,1315].

In Brazil, the spiders causing more serious human accidents belong to the genera Phoneutria, Loxosceles and Latrodectus [5,16,17]. Loxoscelism is the most widely spread spider bite syndrome in the country, occurring with higher frequency from October to March, while most of the phoneutrism cases are recorded from January to May, with higher incidence in the South [5]. Latrodectism presents low incidence, with records mostly from Minas Gerais, São Paulo, Bahia and Santa Catarina states [5]. Two types of spider antivenoms are currently available in Brazil: the polyvalent antivenom against Loxosceles and Phoneutria spiders and the Tityus scorpion, produced from Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus pool, and the anti-Loxosceles antivenom, produced from Loxosceles gaucho, L. intermedia and L. laeta pool [5]. However, the possible interspecific venom variation associated with the geographical distribution of spider species may affect the effectiveness of therapeutic antivenoms against the Amazon spider venoms.

The contribution of different spider species responsible for spider bites to the overall burden needs to be assessed through population- and hospital-based studies. Usually the agent is not identified and the diagnosis is based mostly on clinical and epidemiological features, leading to a limitation in monitoring and properly treating this health problem [5]. Based on fauna distribution data, Phoneutria fera and Phoneutria reidyi likely represent the major species leading to phoneutrism in the region [17]. Loxosceles amazonica and Loxosceles laeta are thought to be the major agents of loxoscelism in the Brazilian Amazon [17,18]. Among Latrodectus species, Latrodectus geometricus, the most widely species found in Brazil, is thought to be the major causative of envenomings [17]. The data on the biology and behavior of these spider species in the Amazon biome remain unclear, especially in the artificial ecotopes with possible differences in spider species composition. Fig 1 shows main species of spiders responsible for bites in the Brazilian Amazon.

Fig 1. Main spider species of medical significance in the Brazilian Amazon.

Fig 1

Phoneutria fera (A) and Phoneutria reydii (B), commonly known as Brazilian wandering spiders, armed spiders ("armadeiras", as they are known in Brazilian Portuguese), or banana spiders, are a genus of aggressive spiders of the Ctenidae family, with potential medical significance to humans due to their neurotoxic venom. Phoneutria fera is a species largely distributed in Brazil, Ecuador, Peru and in the Guyanas. Phoneutria reydii is found in Brazil, Venezuela and the Guyanas. Latrodectus geometricus (C), commonly known as the brown widow, brown button spider, geometric button spider or gray widow ("viúva negra" or "aranha preta", as is known in Brazil), is a medium spider of the family Theridiidae that belongs to a species group of medical interest due to its neurotoxic venom effect on human health. Probably native from Africa, the species is largely distributed in most American countries. Loxosceles amazonica (D) and Loxosceles laeta (E), known as recluse spiders, fiddle-back, violin spiders or reapers (commonly known as "aranha marrom" in Brazil), are non-aggressive venomous spiders belonging to the family Sicariidae, which can induce a variety of clinical symptoms, including dermonecrosis, thrombosis, vascular leakage, haemolysis and persistent inflammation. Loxosceles amazonica is found in Northern and Northeastern Brazilian regions and Loxosceles laeta is found all over South America (Chile, Peru, Ecuador, Argentina, Brazil, Ecuador and Colombia) and in Central America (Guatemala and Honduras). Three specimens of spiders (F) belonging to the Theraphosidae (called "caranguejeiras" and "tarântulas" in Portuguese) with limited medical importance. Although tarantulas are venomous and some bites cause local pain, these generally evolve without systemic manifestations.

A better knowledge of severity due to spider bites would lead to improved management, with expected reduction of sequelae and lethality rates in remote localities in the Brazilian Amazon. The aim of this study was to analyze the profile of spider bites reported in the state of Amazonas in the Western Brazilian Amazon, and to investigate potential risk factors for associated severity.

Methods

Study area and population

The State of Amazonas is located in the Western Brazilian Amazon, comprising an area of 1,570,946.8 km2, with 62 municipalities. The estimated population of the state was 3,807,921 inhabitants in 2010, with 74.2% living in urban zones and 25.8% in rural areas. We included all spider bite cases in the state of Amazonas compulsorily recorded by SINAN from January 1, 2007 to December 31, 2014, based on data report forms used in the investigation and follow-up of cases. Spider bite antivenom is provided free of charge only by the Brazilian Government, linked to SINAN recording, and is not available from the private sector.

Exposures and outcome definitions

Reporting on spider bite’s severity grading and outcomes (discharge or death) is required by SINAN and entered since 2007 by healthcare providers at the time of case notification (which often happens after discharge) in the Amazonas state. The variables analyzed were sex, age, anatomical region of the bite, area of occurrence (rural or urban), work-related injury, time elapsed between the bite and medical assistance, suspected spider genus (Phoneutria, Loxosceles or Latrodectus), severity grading (mild, moderate or severe), outcome (discharge or death), clinical features and antivenom administration data. All variables were checked by two independent researchers before analysis and further investigated for possible association with severity as dependent variables.

Clinical severity of spider bites in this work was classified according to the Brazilian Health Ministry guidelines [5], as presented in Table 1.

Table 1. Brazilian Ministry of Health clinical classification of spider bites.

Case classification Signals and symptoms Antivenon recommendation
Mild Local pain, edema, erythema, sweating and piloerection for Phoneutria bites and absence of systemic manifestations with identification of the spider for Loxosceles bites. Not recommended
Moderate Intense local pain, sweating, occasional vomiting, psychomotor restlessness and arterial hypertension are found in moderate Phoneutria bites; moderate Phoneutria bites are treated with 2–4 vials of the polyvalent antivenom against Loxosceles and Phoneutria spiders and the Tityus scorpion (LPT antivenom). Moderate Loxosceles bites present suggestive features regardless spider identification, nonspecific systemic manifestations (exanthema, fever), with absence of hemolysis 5 vials of LPT or anti-Loxosceles (AL) antivenom
Severe Life-threatening spider bites, with profuse sweating, drooling, lavish vomiting, priapism, shock and/or acute lung edema for Phoneutria bites, and characteristic lesion plus clinical manifestations and/or laboratory evidence of intravascular hemolysis for Loxosceles. i) Severe Phoneutria: 5–10 vials of LPT antivenom
ii) Severe Loxosceles: 10 vials of LPT or AL antivenom.

Latrodectism is scarcely seen in Brazil, including the Amazon, and thus lacks clinical grading by the Brazilian Health Ministry guidelines. There is no anti-Latrodectus antivenom available in Brazil. Local bite-site pain, regional or radiating pain and local or regional diaphoresis are the major signs of latrodectism [10]. Systemic envenomation includes non-specific symptoms such as nausea, vomiting, headache, fatigue, muscle fasciculation, patchy localized paralysis, priapism, arterial hypertension, tachycardia and abdominal pain and rigidity [5,10]. In this study, Latrodectus envenomings presenting only with local signs were classified as mild and those presenting systemic envenomation were classified as moderate/severe.

In order to identify factors associated with spider bite severity, a case-control study was used wherein patients evolving to severe or moderate clinical picture were classified as cases and those with mild bites were included as controls. Cases without clinical classification were not included in the final analysis.

Sociodemographical and environmental indicators

Data on the populations living in municipalities in Amazonas were obtained from the 2010 Census and the intercensus projections developed by the IBGE [19].

Fourteen socioeconomical components and subcomponents were evaluated: (1) Mean Municipal Human Development Index (MMHDI), which is the geometric mean of the indices of the dimensions level of education (EMHDI), longevity (LMHDI) and income (IMHDI), with equal weights, in addition to the three individual dimensions; (2) Gross Municipal Product; (3) Mean Health System Performance Index (MHSPI), which is composed of access (MHSPI Access) and effectiveness (MHSPI Effectiveness) subcomponents; (4) Poverty Rate, the percentage of individuals with a per capita household income less than half the minimum wage in that period; (5) Average Household Income Per Capita, which is the ratio between the sum of the income of all individuals living in permanent private households and the total number of individuals; (6) Income Ratio, which compares the average per capita income of individuals belonging to the richest fifth of this distribution with the average per capita income of individuals belonging to the poorest fifth; (7) Unemployment Rate of the population aged ≥10 years, which is the percentage of the economically active population (EAP) in this age group that was unemployed; (8) Straight-line distance from the Amazonas state capital Manaus, in kilometers, to the municipality seat; and (9) Rural Occupation Rate of the EAP that was working in rural activities. These indicators were obtained from the United Nations Development Programme and from the Brazilian System of Health [20,21].

The three environmental components studied were (1) Percentage of areas under the influence of watercourses in 2010; (2) average annual deforestation increment between 2007 and 2014; (3) average annual deforested area in the municipalities between 2007 and 2014, which was measured by the average annual percentage of the municipal area that lost forest vegetation [22].

Data analysis

To calculate the average annual incidence rates, all new cases of spider bites reported during the study period were added, divided by the sum of the estimated population for each year, and multiplied by 100,000. A map was created with the software ArcMap 10.1 in ArcGIS 10.1 (ESRI, USA) using estimates of the mean incidence by municipality. To study the relationship between the above mentioned sociodemographical and environmental indicators and spider bites incidence, a multiple linear regression model was used. Collinearity and the interaction between the explanatory variables in the analysis that led to the final multiple regression model were appreciated. Correlation between variables was checked. For the final model, only the variables associated with the outcome at a significance level of 0.20 using the backward stepwise technique were selected. Proportions of severe cases were compared by Chi-square test (corrected by Fisher's test if necessary), using individual characteristics from SINAN database and socioeconomical features of the residence municipality as dependente variables; differences were considered statistically significant for p<0.05. The crude Odds Ratio (OR) with its respective 95% Confidence Interval (95%CI) was determined considering severity as the dependent variables. Association between time until medical assistance and distance to the capital was assessed by the Chi-square test. A logistic regression was used for the multivariable analyses and the adjusted Odds Ratios with 95%CI were also calculated separately for SINAN and socioeconomical variables. All variables associated with the outcomes at a significance level of p<0.20 in the univariable analysis were included in the multivariable analysis. Statistical significance was considered if p<0.05 in the Hosmer-Lemeshow goodness-of-fit test. The statistical analyses were performed using STATA statistical package (version 13).

Ethical clearance

This study was approved by the Ethics Review Board (ERB) of the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (approval number 100832/2014). All data were anonymously analyzed, and therefore a waiver of informed consent was given.

Results

Descriptive characteristics of spider bites

According to the official reporting system, 1,181 spider bites were recorded in the Amazonas State from 2007 to 2014. Comprehensive recording of most relevant variables was considered good (>80%). Most of the spider bites occurred in males (777 cases; 65.8%) and 59.5% were reported in rural areas. Seven women were pregnant. The most affected age group was between 16 and 45 years old (601 cases; 50.9%). Admixed ethnicity was the most recorded (80.1%). A total of 75.4% of the patients had up to four years of study. A proportion of 39.7% of the bites were related to work activities. Maintenance and repair services were the most cited by patients with formal occupations (46.4%), followed by agricultural and forestry activities (45.6%). Most bites occurred in the upper limbs (48.8%). Clinico-epidemiological diagnosis of phoneutrism was done in 169 cases (14.3%), loxoscelism in 156 cases (13.2%) and latrodectism in 19 (1.6%). In 837 patients (70.9%), the agent was not identified. Antivenom was prescribed to 39.0% of the patients. Regarding time elapsed from the bite until medical assistance, 36.9% of the cases received treatment within the first hour after the spider bite, 33.0% within 3 hours and 30.1% with more than 3 hours after bite (Table 2).

Table 2. Characteristics of the 1,181 spider bites reported in the State of Amazonas, 2007 to 2014.

Characteristics (completeness) Number %
Sex (n = 1,181; 100%)
Male 777 65.8
Female 404 34.2
Area of occurrence (n = 1,159; 98.1%)
Rural 690 59.5
Urban 469 40.5
Age group (in years) (n = 1,181; 93.9%)
0–15 220 18.6
16–30 300 25.4
31–45 301 25.5
46–60 214 18.1
≥61 146 12.4
Ethnicity (n = 1,145; 96.9%)
Admixed 916 80.1
White 85 7.4
Indian 108 9.4
Black 31 2.7
Asian 5 0.4
Education (in years) (n = 648; 54.9%)
Illiterate 59 9.1
1–4 430 66.3
5–8 71 11.0
≥8 88 13.6
Work-related accident (1,060; 89.8%)
Yes 421 39.7
No 639 60.3
Formal occupation (n = 552; 46.7%)
Maintenance and repair services 256 46.4
Farmer/Fisher 252 45.6
Industry employee 27 4.9
Other 17 3.1
Anatomical region of the bite (n = 1,138; 96.4%)
Head 37 3.2
Upper limbs 555 48.8
Trunk 36 3.2
Lower limbs 510 44.8
Probable type of envenoming (n = 1,181; 100%)
Phoneutrism 169 14.3
Loxocelism 156 13.2
Latrodectism 19 1.6
Non-identified envenoming 837 70.9
Antivenom prescription (n = 1,130; 95.7%)
Yes 441 39.0
No 689 61.0
Time elapsed from bite to medical assistance (hrs) (n = 1,112; 94.2%)
≤1 410 36.9
1–3 367 33.0
4–6 168 15.1
7–12 58 5.2
13–24 51 4.6
>24 58 5.2

Spatial distribution

Incidence rates were unevenly distributed across the Amazonas State, although there were spider bites cases reported from 60 out 62 municipalities. Mapping showed a large area with high incidence rates extending from São Gabriel da Cachoeira (in the Colombian border) to the Uarini/Alvarães municipalities area and in municipalities surrounding Manaus, namely Novo Airão, Iranduba, Rio Preto da Eva and Silves, where incidence rates were higher than 10 cases per 100,000 inhabitants/year. A third hotspot was located in Apuí, in the Southern region of the state. Municipalities with the the higher anual mean incidence were Rio Preto da Eva (91 cases/100.000 inhabitants), followed by Apuí (58 cases/100.000 inhabitants) (Fig 2).

Fig 2. Seasonality of spider bites in the Amazonas State, from 2007 to 2014.

Fig 2

A) An increase in the number of spider bites in the Amazonas between June and July is seen for all years. B) A correlation between the absolute number of cases and the altimetric river levels was notable.

Factors associated to spider bites incidence

The mean incidence rate was 4 cases per 100,000 inhabitants/year. There was a slight increasing trend during the study period, from 2/ 100,000 inhabitants in 2007 to 6/100,000 in the last three years of study. In rural area the rate was 11.8/100,000/year whereas in urban areas it was 2.1/100,000 /year. There was a gradual increase in the number of spider bites from December to April, which remained high until August (Fig 3).

Fig 3. Spatial distribution of spider bites in the State of Amazonas, from 2007 to 2014.

Fig 3

Incidence rates were unevenly distributed across the study area. Extensive hot spots are shown from São Gabriel da Cachoeira (in the Colombian border) to the Uarini/Alvarães municipalities area and Manaus surrounding municipalities, with incidence rates >15/100,000/year. The third hotspot is located in Apuí, in the Southern region of the state, with incidence rates >20/100,000/year.

A multiple linear regression analysis indicated a negative correlation between the spider bites incidence rate and the socioeconomical component poverty rate [Regression coefficient (95% CI) = -0.513 (-0.889 to -0.138); p = 0.008] and the environmental component percentage of areas under the influence of watercourses [Regression coefficient (95% CI) = 0.005 (0.001 to 0.009); p = 0.029] (Table 3).

Table 3. Factors associated with spider bites incidence in the State of Amazonas, 2007 to 2014.

Variables Univariable analysis Multivariable analysis
Regression coefficient (95% CI) p Regression coeficiente (95% CI) p
Socioeconomical components
Distance to capital -0.002 (-0.0135 | 0.009) 0.725
Gross municipal product 0.003 (-0.006 | 0.013) 0.472
MHSPI 3.903 (-2.358 | 10.164) 0.217
MHSPI access 3.102 (-1.234 | 7.438) 0.158
MHSPI effectiveness -2.521 (-9.149 | 4.107) 0.450
MMHDI 42.516 (-21.716 | 106.749) 0.191
EMHDI 22.919 (-18.532 | 64.369) 0.273
LMHDI 52.686 (-78.509 | 183.882) 0.425
IMHDI 48.638 (-18.858 | 116.133) 0.155
Poverty rate -0.389 (-0.759 | -0.019) 0.040 -0.513 (-0.889–0.138) 0.008
Average household income per capita 0.021 (-.0162 | 0.059) 0.260
Income ratio -0.001 (-0.004 | 0.003) 0.697
Rural occupation rate -0.085 (-0.321 | 0.151) 0.473
Enviromental components
Percentage of areas under Watercourses influence 0.003 (0.001 | 0.007) 0.206 0.005 (0.001–0.009) 0.029
Average deforested area 0.002 (-0.004 | 0.008) 0.412
Average deforested area increment 0.158 (-0.057 | 0.374) 0.147

CI: Confidence Interval; MHSPI: Mean Health System Performance Index; IDSUS Access: Health System Performance Index Related to Access; IDSUS Effectiveness: Health System Performance Index Related to Effectiveness; MMHDI: Mean Municipal Human Development Index; EMHDI: Educational Munifcipal Human Development Index; LMHDI: Longevity Municipal Human Development Index; IMHDI: Income Municipal Human Development Index.

Clinical characteristics of spider bites

The most frequent local signs and symptoms observed among spider bite victims were pain (97.3%), edema (65.4%), ecchymosis (6.6%) and pruritus (2.5%) (Table 4). The most frequent local signs and symptoms observed for phoneutrism were pain (97.0%), edema (78.1%), ecchymosis (6.5%) and paresthesia (2.4%). Pain (89.1%), edema (65.4%), ecchymosis (12.2%) and erythema (2.6%) were the most frequent local signs and symptoms for loxoscelism. Pain (100.0%), edema (57.9%) and ecchymosis (5.2%) were the most frequent local signs and symptoms for latrodectism.

Table 4. Baseline clinical features of spider bites reported in the State of Amazonas, 2007 to 2014.

Clinical features at admission Number %
Local signs and symptoms (n = 1,083)
Pain 1,054 97.3
Edema 708 65.4
Ecchymosis 71 6.6
Pruritus 27 2.5
Erythema 24 2.2
Paresthesia 18 1.7
Necrosis 11 1.0
Blisters 3 0.3
Bleeding 1 0.1
Systemic manifestations (n = 1,083)
Vomiting/diarrhea 40 3.6
Neurological signs (including palpebral ptosis and blurred vision) 39 3.5
Fever/chills 16 1.4
Myolysis/hemolysis (myalgia, anemia, dark urine) 12 1.1
Dizziness 10 0.9
Tremors 6 0.5
Headache 5 0.4
Hemorrhage 4 0.3
Sweating 3 0.3
Renal failure 1 0.1
Hypertension 1 0.1
Dyspnea 1 0.1
Abdominal pain 1 0.1
Sepsis 1 0.1
Clotting time (n = 465)
Normal 383 82.4
Abnormal 82 17.6

Vomiting and/or diarrhea (3.6%), neurological symptoms (3.5%), fever/chills (1.4%) and myolisis/hemolysis (1.1%) were the most frequent systemic manifestations (Table 4), with 4.5% of all cases presenting at least one manifestation at admission. Neurological symptoms (5.9%), vomiting/diarrhea (3.0%) and sweating (1.2%) were observed for phoneutrism. The most frequent systemic manifestations observed for loxoscelism were vomiting/diarrhea (4.5%), neurological symptoms (3.2%) and myolysis/hemolysis (2.6%). Neurological symptoms (5.2%) were the only systemic manifestations observed for latrodectism. Clotting time was abnormal in 17.6% of the cases, and 20.8% in suspected loxoscelism.

Local complications were observed in 1.7% of the patients (Table 5). The most frequent local complications were secondary infection (1.1%), extensive necrosis (0.5%), compartmental syndrome (0.4%) and functional deficit (0.4%). Secondary bacterial infection and functional deficit were observed in 0.6% among phoneutrism cases. For loxoscelism, the most frequent local complications were secondary bacterial infection (3.2%), compartmental syndrome (1.9%), extensive necrosis (1.3%) and functional deficit (1.3%). Secondary bacterial infection occurred in 5.6% of the patients presenting latrodectism. No amputation was recorded. In general, the most frequent systemic complications were acute lung injury (0.5%), shock (0.2%), septicemia (0.1%) and renal failure (0.1%). Phoneutrism was not associated with evolution to systemic complications.

Table 5. Clinical complications, severity classification and outcomes of spider bites in patients from the Western Brazilian Amazon, 2007–2014.

Case evolution Total cases (n = 1,082; 93.2%)
Number %
Local complications (n = 1,108)
Secondary infection 12 1.1
Extensive necrosis 5 0.5
Compartmental syndrome 4 0.4
Functional deficit 4 0.4
Systemic complications (n = 1,102)
Acute lung injury 5 0.5
Shock 2 0.2
Septicemia 1 0.1
Renal failure 1 0.1
Final case classification (n = 1,144)
Mild 871 76.1
Moderate 255 22.3
Severe 18 1.6
Outcome (n = 1,117)
Discharged 1,112 99.6
Death 5 0.4

Most cases were mild (76.1%), followed by moderate (22.3%) and severe (1.6%) cases. There were 5 deaths due to spider bites in the study period (three men and two women, aging from 1 to 61 years old), resulting in a 0.4% lethality rate (Table 5). From the seven pregnant women, four presented severity criteria. Severe cases were more frequent for loxoscelism (3.9%), whereas phoneutrism presented 1.2% and there were no severe cases for latrodectism.

Antivenom was provided to 41.7% of the study population, 33.4% of Phoneutria bites and 42% of Loxosceles bites. A proportion of 4.6% of moderate and severe spider bite cases received less than the recommended antivenom dosage. A total of 19% of accidents by Phoneutria considered moderate received less than the recommended dosage and 100% of severe cases were underdosed. For Loxosceles bites, a proportion of 54.9% of moderate cases and 83.3% of severe cases were underdosed. Conversely, 21.2% of the total cases were overdosed and 42.1% of accidents by Latrodectus received antivenom inappropriately. Two from five cases (40%) evolving to death did not receive antivenom, one (20%) received underdosed antivenom and two (40%) had no information of antivenom prescrition (Table 6).

Table 6. Profile of antivenom administration to 1,180 spider bites patients recorded in the Western Brazilian Amazon, 2007–2014.

Antivenom dosage Total cases Phoneutria cases Loxosceles cases
Mild Moderate Severe Mild Moderate Severe Mild Moderate Severe
Underdosage - 45 (17.6%) 7 (38.9%) - 8 (19.1%) 2 (100%) - 28 (62.2%) 5 (83.3%)
As recomended 684 (79.8%) 200 (78.5%) 11 (61.1%) 102 (84.3%) 30 (71.4%) 0 (0%) 80 (86%) 13 (28.9%) 1 (16.7%)
Overdosage 173 (21.2%) 10 (3.9%) 0 (0%) 19 (15.7%) 4 (9.5%) 0 (0%) 13 (14%) 4 (8.9%) 0 (0%)
Total 857 (100%) 255 (100%) 18 (100%) 121 (100%) 42 (100%) 2 (100%) 93 (100%) 45 (100%) 6 (100%)

Factors associated with severity

For 273 cases of severe and moderate spider bites during the study period, 872 mild cases served as controls (Fig 4). Table 7 summarizes the results of the logistic regression evaluating independent factors associated with spider bites severity. Envenomings recorded from urban areas [OR = 2.50 (95%CI = 1.41–3.33; p<0.001)], work-related accidents [OR = 2.09 (95%CI = 1.49–2.94; p<0.001)] and indigenous ethnicity [OR = 2.15 (95%CI = 1.19–3.86; p = 0.011)] were independently associated with a risk of developing severity. Living in a municipality located >300 km away from the state capital Manaus [OR = 1.90 (95%CI = 1.28–2.40; p<0.001)] was independently associated with the risk of developing severity and, conversely, living in a municipality with an MHSPI >median [OR = 0.64 (95%CI = 0.39–0.75; p<0.001)] was independently associated with protection from developing severity (Table 8).

Fig 4. Flow chart of cases and control selection.

Fig 4

Selection of cases and controls was based on the Brazilian Ministry of Health classification. All severe and moderate bites were included as cases, whereas mild bites served as controls.

Table 7. Factors associated with spider bites severity in the State of Amazonas, according to the official surveillance database, 2007 to 2014 (n = 1,180).

Variables Cases (n) % Controls (n) % Crude OR (CI 95%) p Adjusted OR (CI 95%) p
Sex
Male 189 69.2 562 64.4 0.81 (0.60–1.08) 0.147 0.92 (0.66–1.30) 0.628
Female 84 30.8 310 35.6
Age (years)
16–64 206 75.5 638 73.2 1
≤15 41 15.0 170 19.5 1.34 (0.92–1.95) 0.127 1.13 (0.73–1.76) 0.586
≥65 26 9.5 64 7.3 0.79 (0.49–1.29) 0.350
Area of occurrence
Rural 194 71.6 465 54.4 2.13 (1.56–2.86) <0.001 2.50 (1.41–3.33) <0.001
Urban 77 28.4 390 45.6
Work related accident
Yes 141 56.4 268 34.1 2.49 (1.87–3.34) <0.001 2.09 (1.49–2.94) <0.001
No 109 43.6 517 65.9
Schooling (years of study)
≤4 112 56.3 232 54.0 1.10 (0.78–1.54) 0.585
>4 87 43.7 198 46.0
Ethnicity
Admixed 216 80.6 680 80.2 1 1
White 24 8.9 58 6.8 0.77 (0.47–1.27) 0.299
Indian 18 6.7 84 9.9 1.48 (0.87–2.52) 0.147 2.15 (1.19–3.86) 0.011
Black 9 3.4 22 2.6 0.78 (0.35–1.71) 0.530
Asian 1 0.4 4 0.5 1.27 (0.14–11.43) 0.831
Anatomical site
Head 11 4.0 25 3.0 1 1
Upper limbs 140 51.5 400 47.9 1.26 (0.60–2.62) 0.542
Body 4 1.5 31 3.7 3.41 (0.97–12.02) 0.056 1.93 (0.65–5.71) 0.233
Lower limbs 117 43.0 379 45.4 1.42 (0.68–2.98) 0.347
Time until medical assistance (hrs)
<1 96 36.0 305 37.3 1 1
1–3 93 34.8 267 32.7 0.90 (0.65–1.26) 0.546
4–6 45 16.9 116 14.2 0.81 (0.54–1.23) 0.322
7–12 10 3.7 46 5.6 1.44 (0.70–2.98) 0.315
13–24 15 5.6 35 4.3 0.73 (0.38–1.40) 0.349
≥24 8 3.0 48 5.9 1.88 (0.86–4.13) 0.111 1.46 (0.62–3.43) 0.387

OR: Odds Ratio; CI: Confidence Interval.

Table 8. Sociodemographical and environmental indicators associated with spider bites severity in the State of Amazonas, 2007 to 2014 (n = 1,180).

Municipality variables Cases (n) % Controls (n) % Crude OR (CI 95%) p Adjusted OR (CI 95%) p
Distance to capital (in km)
>300 159 58.2 330 37.9 2.29 (1.73–3.01) <0.001 1.90 (1.28–2.40) <0.001
Gross municipal product
>Median 178 65.2 669 76.8 0.56 (0.42–0.76) <0.001
MHSPI
>Median 164 60.1 686 78.8 0.40 (0.30–0.54) <0.001 0.64 (0.39–0.75) <0.001
MHSPI access
>Median 168 61.5 687 78.9 0.43 (0.32–0.57) <0.001
MHSPI effectiveness
>Median 97 35.5 221 25.4 1.62 (1.21–2.17) 0.001
MMHDI
>Median 193 70.7 705 80.9 0.57 (0.42–0.77) <0.001
EMHDI
>Median 186 68.1 693 79.6 0.55 (0.40–0.74) <0.001
LMHDI
>Median 161 59.0 667 76.6 0.44 (0.33–0.59) <0.001
IMHDI
>Median 177 64.8 695 79.8 0.47 (0.35–0.63) <0.001
Average household income per capita
>Median 180 65.9 704 80.8 0.46 (0.34–0.62) <0.001
Income ratio
>Median 84 30.8 211 24.2 1.40 (1.03–1.88) 0.031
Unemployment rate
>Median 140 51.3 579 66.5 0.53 (0.40–0.70) <0.001
Rural occupation rate
>Median 108 39.6 232 26.6 1.80 (1.35–2.40) <0.001

OR: Odds Ratio; CI: Confidence Interval; MHSPI: Mean Health System Performance Index; IDSUS Access: Health System Performance Index Related to Access; IDSUS Effectiveness: Health System Performance Index Related to Effectiveness; MMHDI: Mean Municipal Human Development Index; EMHDI: Educational Municipal Human Development Index; LMHDI: Longevity Municipal Human Development Index; IMHDI: Income Municipal Human Development Index.

Living in a municipality located >300 km away from the state capital Manaus [OR = 1.53 (95%CI = 1.15–2.02; p = 0.003)] and living in a municipality with an MHSPI <median [OR = 1.91 (95%CI = 1.28–2.47; p = 0.002)] were also independently associated with higher odds of antivenom underdosage. No association was found between time until medical assistance and distance to the capital (p = 0.551).

Discussion

Official reporting system shows that spider bites prevail across the study area, with a higher incidence in rural areas. A bias in surveillance database could explain the non-plausible negative correlation between the spider bites incidence and the poverty rate, due to the lower odds of riverine and indigenous populations reaching health centers, probably resulting in underreporting. Actually, using estimates of the rate of people bitten by spiders at least once in their lifetime, epidemiological surveillance in rural and indigenous areas would have a sensitivity of only about 10% in the Western Amazon [8]. Importantly, the high proportion of spider bites as a work-related health problem for rural male populations in the Brazilian Amazon highlights the need for public health strategies aiming to reduce these occupational injuries.

Higher spider bites incidence rates were recorded in municipalities surrounding Manaus and in the Southern region of the state, corresponding to areas with intense deforestation. Phoneutria and Loxosceles, species known to have great potential for adaptation to the man-made environment, were the main causes of bites identified in this study. Bites by Phoneutria occur when the spiders are in shoes, piles of sticks or rubbish, or construction material [16]. Loxosceles are nocturnal spiders well adapted to the domestic environment, under rocks, wood, or tree bark [23]. There is a marked seasonality of spider bites in the Amazonas state, peaking during the period of heaviest rainfalls. This correlation is possible due to the fact that most rainfall floods the natural habitat of spiders, forcing them to seek new shelters, as observed also for scorpions [24]. The percentage of areas under the influence of watercourses correlates with spider bites incidence, suggesting that altimetric levels could influence the contact between human populatons and venomous spiders. There is evidence of seasonal reproduction for Phoneutria in the Amazon, which may affect population abundance [25,26].

The spider bite diagnosis is usually clinical, and definite bites should be based on a clear history of a spider biting the person and then being identified [10]. In this work, only 29.1% of the bites had the causative species identified, among which phoneutrism and loxoscelism prevailed. In general, health services responsible for attending spider bites lack personnel trained in collection and identification of these agents. Identification of spider venom in human tissue has been achieved for Loxosceles spp. [2729] and Phoneutria nigriventer [30], but laboratory diagnosis is not available in endemic areas. Some venomous spiders can usually be identified by the general population, which is sufficient for routine management [31]. However, absence of precise information on spider species limits clinical and epidemiological research [11]. In this series, based on epidemiological surveillance data, spider bites mostly caused only minor effects, basically local pain, in agreement with other works [3237].

Phoneutria was the major agent of arachnidism in the Amazonas State based on clinico-epidemiological diagnosis. In South America and Costa Rica, where this genus is found, clinically important bites are mostly reported from Brazil [16,38,39]. Local pain was the major symptom reported by this group of patients (97%). Bites by Phoneutria spiders cause immediate local pain of variable severity that radiates proximally up the bitten extremity [10]. Local anaesthetics, opioids, non-steroidal anti-inflammatory drugs and arachnid antivenom have been used empirically for treating Phoneutria bites [40,41]. Local edema is less frequent than pain and appeared in 78% of bitten people, in agreement with other estimates in Brazil [39]. In a series of 422 Phoneutria confirmed bites almost 90% showed mild envenomation [16]. In this work, 98.8% of cases were classified as mild or moderate envenomation. Severe envenomation was characterized by persistent vomiting and neurological signs such as palpebral ptosis and blurred vision, in agreement with previous studies [16,42]. The major local complications observed were secondary infection and necrosis in Loxosceles cases. Necrotic ulcers as suspected spider bites are common in primary care and emergency departments, despite scarcity of evidence for all but Loxosceles causing necrotic arachnidism [33]. Although bacterial and fungal causes of necrotic ulcers should always be considered [14,43,44], a proper investigation of Loxosceles is needed in endemic areas such as the Amazon.

Systemic envenoming occurred in 4.5% of all cases, with higher frequency among presumed Loxosceles cases. Nonspecific symptoms such as vomiting and diarrhea, blurred vision and fever were prevalent within this group of patients, and were the only systemic symptoms recorded from presumed Phoneutria and Latrodectus cases. Although most cases of systemic loxoscelism are reported in children [15,4547], in this case series systemic envenoming was reported across all age groups in similar frequencies. The major medical complication of loxoscelism is acute intravascular hemolysis [15,4851], reported in this study in 1.1% of the patients. Acute renal failure was uncommon, in agreement with previous studies [15,45,52,53].

Although this study showed high frequency of abnormal clotting times in Loxosceles patients, only a small proportion evolved with systemic bleeding. Disseminated intravascular coagulopathy (DIC) following Loxosceles arachnidism is scarcely reported in the literature [53,54]. The exact frequency and range of clinical manifestations is difficult to establish because most reports of systemic loxoscelism are of presumed rather than confirmed bites. Viscerocutaneous loxoscelism is much less common than the cutaneous form but the frequency varies in different species [1]. In South America, more than 10% of cases of systemic loxoscelism are reported among envenomings with Loxosceles laeta [15,45] whereas cases caused by Loxosceles gaucho are rare [46].

Local pain was recorded for all patients with suspected Latrodectus bites, followed by edema and ecchymosis. Pain is an almost universal feature of latrodectism and can be local bite-site pain, regional or radiating pain, or back, chest, or abdominal pain [10]. In Australia, local pain radiating up the bitten limb or from the bite site is typical [11,55], whereas in North and South America back and abdominal pain predominate [56,57]. In Bahia State, Brazil, abdominal pain was seen in 17% of the patients [37], which was absent in this case series. In this work, no severe Latrodectus cases were reported, with only one patient evolving with blurred vision as a neurological symptom. In Manaus, Brazilian Amazon, one suspected case of Latrodectus bite, diagnosed only based on clinico-epidemiological criteria, presented headache, abdominal pain, vomiting, muscle spasms, fever, shivering, intense sweating and a significant palpebral edema [58].

Antivenom underdosage was very frequent in this study, namely for Loxosceles bites, possibly contributing to severity. Given the scarcity of data on the pharmacoepidemiology of spider antivenoms from endemic areas, antivenom usage prevalences and determinants of beneficial and adverse drug effects are poorly known. In Brazil, antivenom was prescribed in frequencies ranging from 21% in Bahia State [37] to 47% in the South [45]. In this work, antivenom was administered to 41.7% of the study population, 33.4% for Phoneutria bites and 42% for Loxosceles bites. In Brazil antivenom is less used to treat Phoneutria envenomation but is used widely to treat Loxosceles envenomation [10]. This study reports that more than 20% of the patients received more than the recommended dosage of antivenom according the Brazilian official guidelines [5], showing that the use of antivenom is still based on clinical discretion, which has led to discrepancies in the proportion of patients treated.

The time it takes to reach health centers from remote isolated areas was hypothesized as a risk factor for spider bite severity in the Brazilian Amazon. However, we found that severe cases were recorded irrespective of the time to medical assistance. Thus, even when timely reaching health services, poor availability of effective care in the Amazon remains a significant barrier for treatment initiation in order to prevent poor outcomes. In the state, only one tertiary reference center for treatment of spider bites envenoming is located in Manaus, the capital. Envenomings recorded from rural areas, Indigenous status and living in a municipality located >300 km away from Manaus presented higher odds of developing severity. This indicates that the absence of specialized centers to treat spider bites represents a considerable obstacle to the provision of quality care to patients in remote Amazonian areas. Consistently, living in a municipality with a higher performance of the health system is a protective factor for severity. In low income regions, inadequate health services performance is a very widespread problem [59]. Despite the high incidence of injuries from venomous animals, there is a lack of systematic health-worker training on diagnosis, specific therapy, and clinical management of complications. Systematic updating of all relevant diagnosis and treatment guidelines was recommended as a strategy to improve the assistance performance, as reported for snakebites and scorpion stings in the Amazon [60]. However, few interventions have been evaluated with rigorous cost-effectiveness trials, and such studies are urgently needed to guide policy. Furthermore, ministry of health should actively help translate research findings into action to improve health-worker performance, and thereby improve health [59].

Interestingly, spider antivenom severity correlates with antivenom underdosage in remote areas with lower health system performances. Although data on Loxosceles antivenom efficacy are conflicting and no placebo-controlled trials in human beings have been undertaken [61,62], studies indicate attenuation in dermonecrotic arachnidism in rabbits [63,64] and in the systemic envenoming in mice [64] and rabbits [65]. For Phoneutria antivenoms, antivenom therapy efficacy evidence in humans is still scarcer [10]. A Phoneutria nigriventer antivenom prevented envenomation symptoms in guinea pigs [66]. Although most symptomatic Latrodectus exposures are minor, Latrodectus antivenom is associated with shorter symptom duration [67]; its implementation in clinical routine should be evaluated in areas where this genus presents higher incidences. Moreover, innovation in the logistics of antivenoms distribution is also a priority. Current antivenoms require conservation in adequate facilities (2° to 8°C), which are not always available in these remote settings. In addition, multidisciplinary teams training regarding antivenom administration, side effects management, and case monitoring and surveillance may not be appropriate for indigenous and riverine health services.

In conclusion, i) spider envenomings prevailed across the study area, with a higher incidence in rural areas. This information may help improve control strategies against associated morbidity through increasing effectiveness of antivenoms distribution network and other supportive health services in the Amazon; ii) incidence of spider bites was correlated with the period of heaviest rainfalls and was higher in areas under watercourses influence; iii) spider bites can be painful and lead to local complications but rarely result in life-threatening envenoming; iv) main local complications were dermonecrosis and secondary infection in cases diagnosed as Loxosceles bites; v) underdosage was very frequent, namely for Loxosceles bites; vi) Envenomings recorded from rural areas, Indigenous status and living in a municipality located >300 km away from the state capital Manaus presented higher risk of developing severity; vii) antivenom underdosage coincides with spider bites severity in remote areas of the state with lower health system performances, possibly contributing to severity. There is an urgent need for programmatic efforts to improve case management and antivenom use in the Amazon.

Supporting Information

S1 File. Study dataset.

(XLSX)

S2 File. Written permission from the original copyright holder of Fig 1.

(PDF)

S3 File. Written permission from the original copyright holder of Fig 2.

(PDF)

Acknowledgments

We are grateful to the Health Surveillance Foundation of Amazonas (FVS-AM) for providing data on spider bites from the official surveillance system. We thank Antonio Domingos Brescovit (Instituto Butantan) and Paulo Bernarde (Universidade Federal do Acre), for the specimens’ pictures.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This study was supported by the PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq number 001/2013). JLS is a fellow from Fogarty Global Health [R25TW009337]. MVGL is a level 1 fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Isbister GK, Fan HW. Spider bite. Lancet 2011; 378: 2039–2047. 10.1016/S0140-6736(10)62230-1 [DOI] [PubMed] [Google Scholar]
  • 2.Braitberg G, Segal L. Spider Bites: Assessment and Management. Aust Fam Physician 2009; 38: 862–867. [PubMed] [Google Scholar]
  • 3.Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2013; 52: 1032–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Robinson J, Wylie C, Lynch C, Lynch A-M. Practice Standards for Australian Poisons Information Centres. 2014; 18 p. Available: https://www.health.qld.gov.au/poisonsinformationcentre/docs/poison-prac-standards.pdf [Google Scholar]
  • 5.Brazilian Ministry of Health. Caderno 14-Acidentes por Animais Peçonhentos. Guia de vigilância epidemiológica. Brasília: Brazilian Ministry of Health; 2009. p 23.
  • 6.Brazilian Ministry of Health. Incidência (100.000 hab.) de casos de acidentes por aranhas. Brasil, Grandes Regiões e Unidades Federadas. 2000 a 2013; 2015. Available: http://u.saude.gov.br/images/pdf/2014/julho/14/Tabela-13---INCIDENCIA-CASOS---aranha---2000-a-2013---21-05-2014.pdf
  • 7.Brazilian Ministry of Health. Casos de acidentes por aranhas. Brasil, Grandes Regiões e Unidades Federadas. 2000 a 2013; 2015. Available: http://u.saude.gov.br/images/pdf/2014/julho/14/Tabela-12---CASOS---aranha---2000-a-2013---21-05-2014.pdf
  • 8.Pierini S V, Warrell DA, de Paulo A, Theakston RD. High incidence of bites and stings by snakes and other animals among rubber tappers and Amazonian Indians of the Juruá Valley, Acre State, Brazil. Toxicon 1996; 34: 225–236. [DOI] [PubMed] [Google Scholar]
  • 9.Brazilian Ministry of Health. Óbitos por aranhas. Brasil, Grandes Regiões e Unidades Federadas. 2000 a 2013; 2015. Available: http://u.saude.gov.br/images/pdf/2014/julho/14/Tabela-14---OBITOS---aranha---2000-a-2013---21-05-2014.pdf
  • 10.Isbister GK, Gray MR, Balit CR, Raven RJ, Stokes BJ, Porges K, et al. Funnel-web spider bite: a systematic review of recorded clinical cases. Med J Aust. 2005; 182: 407–411. [DOI] [PubMed] [Google Scholar]
  • 11.Isbister GK, Gray MR. Latrodectism: A prospective cohort study of bites by formally identified redback spiders. Med J Aust. 2003; 179: 88–91. [DOI] [PubMed] [Google Scholar]
  • 12.Maretić Z. Latrodectism: variations in clinical manifestations provoked by Latrodectus species of spiders. Toxicon 1983; 21: 457–466. [DOI] [PubMed] [Google Scholar]
  • 13.Futrell JM. Loxoscelism. Am J Med Sci. 1992; 304: 261–267. [DOI] [PubMed] [Google Scholar]
  • 14.Wasserman GS, Anderson PC. Loxoscelism and necrotic arachnidism. J Toxicol-Clin Toxicol. 1984; 21: 451–472. [DOI] [PubMed] [Google Scholar]
  • 15.Schenone H, Saavedra T, Rojas A, Villaroel F. Loxoscelismo en Chile. Estúdios epidemiológicos, clínicos y experimentales. Rev Inst Med Trop São Paulo 1989; 31: 403–415. [DOI] [PubMed] [Google Scholar]
  • 16.Bucaretchi F, Deus-Reinaldo CR, Hyslop S, Madureira PR, De Capitani EM, Vieira RJ. A clinico-epidemiological study of bites by spiders of the genus Phoneutria. Rev Inst Med Trop Sao Paulo 2000; 42: 17–21. [DOI] [PubMed] [Google Scholar]
  • 17.Lucas S. Spiders in Brazil. Toxicon 1988; 26: 759–772. [DOI] [PubMed] [Google Scholar]
  • 18.Gertsch E. The spider genus Loxosceles in South America (Araneae, Scytodidae). Bull Am Mus Natn Hist 1967; 136: 117–174. [Google Scholar]
  • 19.Instituto Brasileiro de Geografia e Estatística. Atlas of the 2010 population census. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística. 2013; 156 p. Available: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/default_atlas.shtm
  • 20.United States of America. United Nations Development Programme. 2015. Available: http://www.undp.org/
  • 21.Brazilian Ministry of Health. SUS—Sistema Único de Saúde. 2015. Available: http://www2.datasus.gov.br/DATASUS/index.php
  • 22.HidroWeb. Hydrological Information System. 2015. Available: http://hidroweb.ana.gov.br
  • 23.Tambourgi DV, Gonçalves-de-Andrade RM, van den Berg CW. Loxoscelism: From basic research to the proposal of new therapies. Toxicon 2010; 56: 1113–1119. 10.1016/j.toxicon.2010.01.021 [DOI] [PubMed] [Google Scholar]
  • 24.Queiroz AM, Sampaio VS, Mendonça I, Fé NF, Sachett J, Ferreira LCL, et al. Severity of Scorpion Stings in the Western Brazilian Amazon: A Case-Control Study. PLoS One 2015; 10: e0128819 10.1371/journal.pone.0128819 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Torres-Sanchez MP. Padrões espaciais de abundância, ciclo reprodutivo e variação de tamanho de adultos de Phoneutria fera Perty e Phoneutria reidyi F.O.Pickard-Cambridge (Araneae, Ctenidae) na Reserva Florestal Adolpho Ducke, Amazonas, Brasil. Manaus: Instituto Nacional de Pesquisas da Amazônia/Fundação Universidade do Amazonas; 2000.
  • 26.Gasnier TR, Höfer H. Patterns of abundance of four species of wandering spiders (Ctenidae, Ctenus) in a forest in Central Amazonia. J Arachnol. 2001; 29: 95–103. [Google Scholar]
  • 27.Barbaro KC, Cardoso JLC, Eickstedt VRD, Mota I. IgG antibodies to Loxosceles sp. spider venom in human envenoming. Toxicon 1992; 30: 1117–1121. [DOI] [PubMed] [Google Scholar]
  • 28.Stoecker W V., Green JA, Gomez HF. Diagnosis of loxoscelism in a child confirmed with an enzyme-linked immunosorbent assay and noninvasive tissue sampling. J Am Acad Dermatol. 2006; 55: 888–890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.McGlasson DL, Green JA, Stoecker WV, Babcock JL, Calcara DA (2009) Duration of Loxosceles reclusa venom detection by ELISA from swabs. Clin Lab Sci. 2009; 22: 216–222. [PMC free article] [PubMed] [Google Scholar]
  • 30.Chávez-Olórtegui C, Bohórquez K, Alvarenga LM, Kalapothakis E, Campolina D, Maria WS, et al. Sandwich-ELISA detection of venom antigens in envenoming by Phoneutria nigriventer spider. Toxicon 2001; 39: 909–911. [DOI] [PubMed] [Google Scholar]
  • 31.Isbister GK. Data collection in clinical toxinology: debunking myths and developing diagnostic algorithms. J Toxicol Clin Toxicol. 2002; 40: 231–237. [DOI] [PubMed] [Google Scholar]
  • 32.Isbister GK, Gray MR. A prospective study of 750 definite spider bites, with expert spider identification. QJM. 2002; 95: 723–731. [DOI] [PubMed] [Google Scholar]
  • 33.Isbister GK, Gray MR. White-tail spider bite: a prospective study of 130 definite bites by Lampona species. Med J Aust. 2003; 179: 199–202. [DOI] [PubMed] [Google Scholar]
  • 34.Isbister GK, Gray MR. Black house spiders are unlikely culprits in necrotic arachnidism: a prospective study. Intern Med J. 2004; 34: 287–289. [DOI] [PubMed] [Google Scholar]
  • 35.Isbister GK, Framenau VW. Australian wolf spider bites (Lycosidae): clinical effects and influence of species on bite circumstances. J Toxicol Clin Toxicol. 2004; 42: 153–161. [DOI] [PubMed] [Google Scholar]
  • 36.Artaza O, Fuentes J, Schindler R. Latrodectism: clinico-therapeutical evaluation of 89 cases. Rev Med Chil. 1982; 110: 1101–1105. [PubMed] [Google Scholar]
  • 37.Lira-da-Silva RM, Matos GB, Sampaio RO, Nunes TB. Retrospective study on Latrodectus stings in Bahia, Brazil. Rev Soc Bras Med Trop. 1995; 28: 205–210. [DOI] [PubMed] [Google Scholar]
  • 38.Bucaretchi F, Mello SM, Vieira RJ, Mamoni RL, Blotta MHSL, Antunes E, et al. Systemic envenomation caused by the wandering spider Phoneutria nigriventer, with quantification of circulating venom. Clin Toxicol (Phila). 2008; 46: 885–889. [DOI] [PubMed] [Google Scholar]
  • 39.Antunes E, Malaque CMS. Mecanismo de ação do veneno de Phoneutria e aspectos clínicos do foneutrismo. In: Cardoso JLC, França FOS, Wen FH, Malaque CMS. Animais Peçonhentos no Brasil, Biologia, Clínica e Terapêutica dos Acidentes. São Paulo: Sarvier; 2003. pp. 150–159.
  • 40.Chahl L, Kirk E (1975) Toxins which produce pain. Pain 1975; 1: 3–49. [DOI] [PubMed] [Google Scholar]
  • 41.Gewehr C, Oliveira SM, Rossato MF, Trevisan G, Dalmolin GD, Rigo FK, et al. Mechanisms Involved in the Nociception Triggered by the Venom of the Armed Spider Phoneutria nigriventer. PLoS Negl Trop Dis. 2013; 7: e2198 10.1371/journal.pntd.0002198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Gomez M V, Kalapothakis E, Guatimosim C, Prado MM. Phoneutria nigriventer venom: A cocktail of toxins that affect ion channels. Cell Mol Neurobiol. 2002; 22: 579–588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Isbister GK, Whyte IM. Suspected white-tail spider bite and necrotic ulcers. Intern Med J. 2004; 34: 38–44. [DOI] [PubMed] [Google Scholar]
  • 44.Swanson DL, Vetter RS. Loxoscelism. Clin Dermatol. 2006; 24: 213–221. [DOI] [PubMed] [Google Scholar]
  • 45.Sezerino UM, Zannin M, Coelho LK, Gonçalves J, Grando M, Mattosinho SG, et al. A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans R Soc Trop Med Hyg. 1998; 92: 546–548. [DOI] [PubMed] [Google Scholar]
  • 46.Málaque CMSA, Castro-Valencia JE, Cardoso JLC, França FODS, Barbaro KC, Fan HW. Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2002; 44: 139–143. [DOI] [PubMed] [Google Scholar]
  • 47.Elbahlawan LM, Stidham GL, Bugnitz MC, Storgion SA, Quasney MW. Severe systemic reaction to Loxosceles reclusa spider bites in a pediatric population. Pediatr Emerg Care 2005; 21: 177–180. [PubMed] [Google Scholar]
  • 48.McDade J, Aygun B, Ware RE. Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents. J Pediatr. 2010; 156: 155–157. 10.1016/j.jpeds.2009.07.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Taylor EH, Denny WF. Hemolysis, renal failure and death, presumed secondary to bite of brown recluse spider. South Med J. 1996; 59: 1209–1211. [DOI] [PubMed] [Google Scholar]
  • 50.Lane DR, Youse JS. Coombs-positive hemolytic anemia secondary to brown recluse spider bite: a review of the literature and discussion of treatment. Cutis 2004; 74: 341–347. [PubMed] [Google Scholar]
  • 51.Minton SA, Olson C. A case of spider bite with severe hemolytic reaction. Pediatrics 1964; 33: 283–284. [PubMed] [Google Scholar]
  • 52.Souza AL, Malaque CM, Sztajnbok J, Romano CC, Duarte AJ, Seguro AC. Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury. Toxicon 2008; 51: 151–156. [DOI] [PubMed] [Google Scholar]
  • 53.Williams ST, Khare VK, Johnston GA, Blackall DP. Severe intravascular hemolysis associated with brown recluse spider envenomation. A report of two cases and review of the literature. Am J Clin Pathol. 1995; 104: 463–467. [DOI] [PubMed] [Google Scholar]
  • 54.Vorse H, Seccareccio P, Woodruff K, Humphrey GB. Disseminated intravascular coagulopathy following fatal brown spider bite (necrotic arachnidism). J Pediatr. 1972; 80: 1035–1037. [DOI] [PubMed] [Google Scholar]
  • 55.Isbister GK, Brown SGA, Miller M, Tankel A, Macdonald E, Stokes B, et al. A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism-the RAVE study. QJM. 2008; 101: 557–565. 10.1093/qjmed/hcn048 [DOI] [PubMed] [Google Scholar]
  • 56.Artaza O, Fuentes J, Schindler R. Latrodectism: clinico-therapeutical evaluation of 89 cases. Rev Med Chil. 1982; 110: 1101–1105. [PubMed] [Google Scholar]
  • 57.Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med. 1992; 21: 782–787. [DOI] [PubMed] [Google Scholar]
  • 58.Souza ARB, Bürnheim PF, Lima CSC. Report of a case of latrodectism occurred in Manaus, Amazonas, Brazil. Rev Soc Bras Med Trop. 1998; 31: 95–98. [PubMed] [Google Scholar]
  • 59.Rowe AK, de Savigny D, Lanata CF, Victora CG. How can we achieve and maintain high-quality performance of health workers in low-resource settings? Lancet. 2005; 9490: 1026–1035. [DOI] [PubMed] [Google Scholar]
  • 60.Hui Wen F, Monteiro WM, Moura da Silva AM, Tambourgi DV, Mendonça da Silva I, Sampaio VS, et al. Snakebites and Scorpion Stings in the Brazilian Amazon: Identifying Research Priorities for a Largely Neglected Problem. PLoS Negl Trop Dis. 2015; 9: e0003701 10.1371/journal.pntd.0003701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Isbister GK, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol. 2003; 41: 291–300. [DOI] [PubMed] [Google Scholar]
  • 62.Pauli I, Puka J, Gubert IC, Minozzo JC. The efficacy of antivenom in loxoscelism treatment. Toxicon 2006; 48: 123–137. [DOI] [PubMed] [Google Scholar]
  • 63.Gomez H, Miller M. Intradermal Anti-Loxosceles Fab Fragments Attenuate Dermonecrotic Arachnidism. Acad Emerg Med. 1999; 6: 1195–1202. [DOI] [PubMed] [Google Scholar]
  • 64.de Roodt AR, Estevez-Ramírez J, Litwin S, Magaña P, Olvera A, Alagón A. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms. J ClinToxicol (Phila). 45: 678–687. [DOI] [PubMed] [Google Scholar]
  • 65.Pauli I, Minozzo JC, da Silva PH, Chaim OM, Veiga SS. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia). Toxicon 2009; 53: 660–71. 10.1016/j.toxicon.2009.01.033 [DOI] [PubMed] [Google Scholar]
  • 66.De Roodt AR, Gutiérrez LR, Rufino CR, Lago NR, Montenegro JL. Obtention of an antivenom against Phoneutria nigriventer (Arachnida; Ctenidae) venom. Arch Argent Pediatr. 2011; 109: 62–65. 10.1590/S0325-00752011000100014 [DOI] [PubMed] [Google Scholar]
  • 67.Monte AA, Bucher-Bartelson B, Heard KJ. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review. Ann Pharmacother. 2011; 45: 1491–1498. 10.1345/aph.1Q424 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Study dataset.

(XLSX)

S2 File. Written permission from the original copyright holder of Fig 1.

(PDF)

S3 File. Written permission from the original copyright holder of Fig 2.

(PDF)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES